Christopher van Dyck MD

Professor of Psychiatry, Neurology, and Neurobiology; Director, Alzheimer's Disease Research Unit

Departments & Organizations

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Neuroscience

Yale Medical Group

Office of Student ResearchInterdepartmental Neuroscience ProgramNeurobiologyNeurology | Dorothy Adler Geriatric Assessment Center | Psychiatry: Alzheimer's Disease Research Unit; Aging & Geriatric Psychiatry, Division of


Christopher H. van Dyck, MD, is Professor of Psychiatry, Neurology, and Neurobiology, and Director of the Alzheimer's Disease Research Unit at Yale. His research interests include therapeutic, neuroimaging and genetic studies of Alzheimer's disease (AD) and healthy cognitive aging. Dr. van Dyck is very active in AD therapeutic research. Since 1992 he has participated in 70+ multicenter clinical trials for AD and MCI and has authored several of the trial publications. He serves on the Steering Committees of the NIA Alzheimer's Disease Cooperative Study (ADCS) and Alzheimer's Disease Neuroimaging Initiative (ADNI). Dr. van Dyck’s other significant scholarly contributions include dopamine transporter imaging in healthy aging and the apolipoprotein E e4 Phenotype of AD. In 2005 he received the "Compassion and Cure" Award from the Alzheimer's Association.


  • B.A., Yale University , 1978
  • M.D., Northwestern University , 1984

Selected Publication

  • Mitsis EM, Cosgrove KP, Staley JK, Bois F, Frohlich EB, Tamagnan GD, Estok KM, Seibyl JP, van Dyck CH. Age-related decline in nicotinic receptor availability with [123I]5-IA-85380 SPECT. Neurobiol Aging 2009;30(9):1490-7.

Latest Honor and Recognition

  • Best Doctors in New York (Top 2%), as Featured in New York Magazine(2005-2009) , Castle Connolly